[Hemosorption in the combined treatment of patients with symptomatic malignant hypertension]. 1987

A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov

The paper is concerned with the results of multiple modality therapy of 35 patients with symptomatic malignant renal hypertension. Hemosorption on carbon of CKH rank was employed as one of the therapeutic modalities. Hemosorption resulted in a considerable decrease in arterial pressure, improved a picture of the fundus of the eye, the level of aldosterone in the blood returned to normal, and in the patients with the first signs of disorders of nitrogen excretory function it resulted in its normalization. Only in the patients with terminal renal failure did hemosorption result in a temporary hypotensive and detoxication effect.

UI MeSH Term Description Entries
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
July 1991, Vrachebnoe delo,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
August 1985, Khirurgiia,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
July 1991, Vrachebnoe delo,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
February 1983, Vrachebnoe delo,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
November 1986, Khirurgiia,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
January 1986, Terapevticheskii arkhiv,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
January 1955, Polskie Archiwum Medycyny Wewnetrznej,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
December 1983, Vestnik dermatologii i venerologii,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
February 1990, Vrachebnoe delo,
A I Kutsenko, and G G Arabidze, and V V Kukharchuk, and A Iu Zaruba, and D R Rakhmedov
November 1982, Klinicheskaia khirurgiia,
Copied contents to your clipboard!